The prevalence of antinuclear antibodies in patients with schizophrenia spectrum disorders: results from a large cohort study
Authors:
- Hans C van MierloHMHans C van Mierlo
- the GROUP investigatorsTIthe GROUP investigators
Open Access
- 6 May 2015
- journal article
- research article
- Published by Springer Nature in Schizophrenia
- Vol. 1 (1) , 15013
Abstract
Npj Schizophrenia publishes high-quality research relevant to all aspects of schizophrenia and psychosis. The journal is fully open access and published in partnership by Nature Publishing Group and the Schizophrenia International Research Society.Keywords
This publication has 28 references indexed in Scilit:
- Evidence‐based guidelines for the use of immunologic tests: Antinuclear antibody testingArthritis Care & Research, 2002
- Leukocytes and organ-nonspecific autoantibodies in schizophrenics and their siblings: markers of vulnerability or disease?Biological Psychiatry, 1996
- Antinuclear autoantibodies in chronic schizophreniaActa Psychiatrica Scandinavica, 1995
- Antinuclear and gastric parietal cell autoantibodies in schizophrenic patientsBiological Psychiatry, 1992
- Neuroleptic-associated autoantibodies a prevalence studyBiological Psychiatry, 1990
- Factors related to the presence of autoantibodies in patients with chronic mental disordersBiological Psychiatry, 1990
- Chlorpromazine‐induced lupus anticoagulant and associated immunologic abnormalitiesAmerican Journal of Hematology, 1982
- ANTINUCLEAR FACTORS IN RELATION TO AGE, SEX, MENTAL DISEASE AND TREATMENT WITH PHENOTHIAZINESActa Psychiatrica Scandinavica, 1974
- CHLORPROMAZINE‐INDUCED ANTINUCLEAR FACTORSActa Medica Scandinavica, 1970
- A Serum Factor in Lupus Erythematosus with Affinity for Tissue NucleiBMJ, 1957